Payments giant Visa is reportedly planning to eliminate approximately 2,600 jobs, or 7% of its workforce, with cuts focused on technology and product divisions, according to a Bloomberg report citing a staff memo.
Shares of Palantir Technologies are falling as investors lock in recent gains and weigh a high valuation, insider selling, and broader market weakness ahead of its August 3 earnings report.
Shares of ProMIS Neurosciences (NASDAQ:PMN) jumped after the company reported positive interim safety data for its Alzheimer's drug candidate, PMN310, which showed no cases of a serious brain swelling side effect in a Phase 1b trial.
The payments company boosted its 2026 profit guidance after reporting second-quarter results that topped analyst estimates, signaling early progress in its strategic overhaul as it navigates takeover speculation.
Shares of Altimmune Inc. jumped Tuesday after the company reported its drug candidate, pemvidutide, met its primary and key secondary endpoints in a mid-stage trial for treating alcohol use disorder.
Shares of the beverage giant surged after it reported second-quarter results that topped analyst estimates and raised its full-year forecast, citing strong demand and the resolution of a recent operational issue.
Global investor positioning remains broadly constructive but is becoming increasingly concentrated, with notable weakness emerging in U.S. tech and small-cap stocks, according to a new analysis from Citi.
JetBlue Airways reported a wider-than-expected second-quarter loss, driven by an 81% surge in fuel expenses that offset strong travel demand. The carrier reinstated its full-year revenue outlook and set a new long-term profit target.
Corning shares fell sharply after its Q2 2026 earnings report included a cautious forecast, signaling a potential slowdown in spending from wireless carriers that raised concerns for its Optical Communications segment.
